Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Sublingual caffeine to shorten recovery and reduce agitation after general anesthesia in older adults

Official title: Efficacy of Sublingual Caffeine on Reducing Recovery Time and Postoperative Agitation in Elderly Patients Undergoing General Anesthesia: A Double-Blind Randomized Controlled Trial

Run by Cairo University · NCT07536568 · Data updated 2026-11-12

This trial will test whether a single dose of sublingual caffeine helps people aged 65 and older wake up faster and have less postoperative agitation after elective eye surgery under general anesthesia.

More General Anesthesia trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment50 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedApril 18, 2026
Main results expectedJuly 15, 2026
Study endsAugust 30, 2026
Registry record updatedApril 21, 2026
Trial IDNCT07536568 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 65 or older with ASA II status scheduled for elective ophthalmology surgery under general anesthesia who do not have major cardiac disease, cognitive impairment, seizures, substance abuse, or chronic use of CNS stimulants or sedatives.

Probably not a fit

Patients with severe systemic disease (ASA III or higher), uncontrolled arrhythmias or hypertension, known caffeine allergy, preexisting dementia, seizure disorders, substance abuse, emergency surgeries, or procedures longer than three hours are unlikely to be eligible or benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study gives eligible patients either sublingual caffeine citrate or a matching placebo around the time of emergence from general anesthesia to compare recovery times and the incidence of postoperative agitation. Participants are adults aged 65 or older with ASA physical status II scheduled for elective ophthalmology procedures under general anesthesia, and those with significant cardiac disease, cognitive impairment, seizure disorders, substance abuse, or very long or emergency surgeries are excluded. Caffeine is a CNS stimulant that blocks adenosine A1/A2A receptors and has been shown to speed emergence from anesthesia in some settings, providing the biological rationale for the intervention. The study measures time to recovery and occurrence of agitation/delirium in the immediate postoperative period to determine if sublingual caffeine offers clinical benefit in this vulnerable population.

Why it matters

Potential benefit: If successful, the intervention could shorten time to wakefulness and reduce episodes of postoperative agitation in older patients, potentially lowering complications and shortening hospital stays.

How similar studies have gone: Prior studies in mixed adult populations have shown that caffeine can speed emergence from anesthesia, but evidence specifically demonstrating reduced postoperative agitation or delirium in elderly surgical patients is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 65 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) physical status II.
* Scheduled for elective ophthalmology surgery under general anesthesia.

Exclusion Criteria:

* History of severe cardiac arrhythmias or uncontrolled hypertension.
* ASA III patients were excluded to reduce the risk of adverse events in elderly patients with severe systemic diseases.
* Known allergy or hypersensitivity to caffeine.
* Pre-existing cognitive impairment or dementia (All patients will undergo preoperative cognitive screening using the online Mini-Cog test or Montreal Cognitive Assessment \[MoCA\]).
* History of seizures or epilepsy.
* History of alcohol or drug abuse.
* Chronic use of CNS stimulants or sedatives.
* Emergency surgeries.
* Prolonged procedures for more than 3 hours.

Where it's running

  • Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.